236 related articles for article (PubMed ID: 30027448)
21. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
[TBL] [Abstract][Full Text] [Related]
22. Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid.
Rigas PK; Kase S; Rao NA
Eur J Ophthalmol; 2009; 19(5):702-7. PubMed ID: 19787585
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of PD-L1 and PD-1 expression in aggressive eyelid sebaceous gland carcinoma and its clinical significance.
Jayaraj P; Sen S
Indian J Ophthalmol; 2019 Dec; 67(12):1983-1987. PubMed ID: 31755433
[TBL] [Abstract][Full Text] [Related]
24. Sebaceoma of the eyelid.
Yonekawa Y; Jakobiec FA; Zakka FR; Fay A
Ophthalmology; 2012 Dec; 119(12):2645.e1-4. PubMed ID: 23207023
[No Abstract] [Full Text] [Related]
25. Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
Yunoki T; Tabuchi Y; Hayashi A
Anticancer Res; 2017 Apr; 37(4):1931-1934. PubMed ID: 28373462
[TBL] [Abstract][Full Text] [Related]
26. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
27. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
28. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
[TBL] [Abstract][Full Text] [Related]
29. Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid.
Tanahashi J; Kashima K; Daa T; Yada N; Fujiwara S; Yokoyama S
J Cutan Pathol; 2009 Sep; 36(9):983-6. PubMed ID: 19017040
[TBL] [Abstract][Full Text] [Related]
30. Expression of Shh and Wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: clinicopathologic study.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):370-7. PubMed ID: 23249701
[TBL] [Abstract][Full Text] [Related]
31. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
Lam SC; Li EYM; Yuen HKL
Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
[TBL] [Abstract][Full Text] [Related]
32. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
[TBL] [Abstract][Full Text] [Related]
33. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Kan LW; Leu YS; Tzen CY; Wu CH
Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
[TBL] [Abstract][Full Text] [Related]
34. Reverse masquerade: primary eyelid amyloidosis mimicking sebaceous gland carcinoma.
Shahid Alam M
Orbit; 2022 Jun; 41(3):392. PubMed ID: 33779482
[No Abstract] [Full Text] [Related]
35. An Immunohistochemical Study of Epidermal Growth Factor Receptor in Sebaceous Carcinoma of the Eyelid: A Potential Therapeutic Target.
Zhang P; Tang L; Gao H; Xu H; Zhang W; Lin J; Chen S
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):377-380. PubMed ID: 35093989
[TBL] [Abstract][Full Text] [Related]
36. Outcome of periocular sebaceous gland carcinoma.
Burns SJ; Foss AJ; Butler TK
Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):353-5. PubMed ID: 16234697
[TBL] [Abstract][Full Text] [Related]
37. Eyelid Sebaceous Gland Carcinoma with Extensive Pagetoid Spread.
Barsegian A; Shinder R
Ophthalmology; 2017 Jun; 124(6):858. PubMed ID: 28528830
[No Abstract] [Full Text] [Related]
38. Neoadjuvant Systemic Chemotherapy in the Management of Extensive Eyelid Sebaceous Gland Carcinoma: A study of 10 Cases.
Kaliki S; Ayyar A; Nair AG; Mishra DK; Reddy VA; Naik MN
Ophthalmic Plast Reconstr Surg; 2016; 32(1):35-9. PubMed ID: 25675161
[TBL] [Abstract][Full Text] [Related]
39. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
Rishi K; Font RL
Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
[TBL] [Abstract][Full Text] [Related]
40. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.
Chao AN; Shields CL; Krema H; Shields JA
Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
